Skip to content
Riskpilot
← Back to search
Sign in
Get full access
LY - FOR DEG MED EN OPPVEKST PREGET AV VOKSNES RUS
FLI
Active
Org 994105663
Gullhaugveien 1, 0484
Oslo
Activities of other membership organisations n.e.c.
· NACE 9499
Est. 2009
8 employees
www.barnavrus.no
Watchlist
Share
Norway
/
Companies
/
Activities of other membership organisations n.e.c.
/
LY - FOR DEG MED EN OPPVEKST PREGET AV VOKSNES RUS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
MK
May Kristin Oudmayer
Chief Executive Officer
Chief Executive Officer
2024
MS
Marius Sjømæling
Chief Executive Officer
Chief Executive Officer
2010
Board of directors
Non-executive oversight
Name
Role
Member since
Current (12)
CD
Cathrine Daniela Trosterud
Board of Directors
2025
ME
Marius Eriksen
Chairman
2024
MN
Monika Nordhus
Board of Directors
2019
HB
Hans-Christian Bjerk
Deputy Chairman
2024
BM
Bente Margrethe Weimand
Board of Directors
2024
GK
Guro Krogsæther Bodøgaard
Board of Directors
2026
MK
Madelen Kristoffersen Endresen
Board of Directors
2025
KL
Kari Lossius
Board of Directors
2024
VM
Vilde Maria Krogvold
Board of Directors
2025
ES
Ellen Stenslie
Deputy Chairman
2025
HP
Henning Pettersen
Board of Directors
2025
GB
Guro Bodøgaard Krogsæther
Board of Directors
2024
Former (7)
EN
Elisabeth Nordhus Blankenberg Lied
Board of Directors
2019 – 2024
EN
Egil Nygaard
Board of Directors
2019 – 2024
CH
Cecilie Haugland Nikolaisen
Chairman
2019 – 2024
CH
Caroline Hurlén Paus-Knudsen
Board of Directors
2019 – 2024
SJ
Stian Johansen
Board of Directors
2019 – 2024
CM
Cecilia Margarita Dinardi
Board of Directors
2019 – 2024
MI
Mona Irene Skjeklesæther Pettersen
Board of Directors
2019 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on LY - FOR DEG MED EN OPPVEKST PREGET AV VOKSNES RUS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
